Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 6/2021

01-09-2021 | Type 2 Diabetes | Original Contribution

Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis

Authors: Ursula Schwab, Andrew N. Reynolds, Taisa Sallinen, Angela Albarosa Rivellese, Ulf Risérus

Published in: European Journal of Nutrition | Issue 6/2021

Login to get access

Abstract

Purpose

Advice regarding the intake of dietary fats is particularly relevant to those with type 2 diabetes, given their increased risk of cardiovascular disease.

Methods

We have undertaken a systematic review of fat intakes and cardiovascular disease risk in adults with type 2 diabetes using an online search strategy to 24 April 2020, augmented with hand searching. Searches, extraction, and risk of bias assessments were undertaken by two researchers. The quality of evidence was assessed with GRADE protocols.

Results

We identified five eligible prospective studies of 22,591 participants followed for on average 9.8 years, and one trial of 14 participants with type 2 diabetes. Limited data were available; however, replacement analyses of saturated fat with polyunsaturated fat (RR for 2% energy replacement 0.87 95% CI: 0.77–0.99) or carbohydrate (RR for 5% energy replacement 0.82 95% CI: 0.67–1.00) was associated with reduced cardiovascular disease occurrence. Higher polyunsaturated: saturated fat intake was also associated with reduced cardiovascular disease occurrence (RR 0.75 95% CI: 0.57–0.98). The quality of evidence was low to very-low.

Conclusion

Although only limited data were available, replacement of saturated fats with other macronutrients, such as polyunsaturated fats, was associated with reduced cardiovascular disease occurrence. Supporting evidence from research in the general population increases confidence in these findings. Until more data are available to better comment on dietary fat intakes in cardiovascular disease risk of those with type 2 diabetes, it appears appropriate that saturated fats be replaced in the diet with other macronutrients, such as polyunsaturated fats.
Appendix
Available only for authorised users
Literature
1.
De Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, Uleryk E, Budylowski P, Schünemann H, Beyene J (2015) Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 351:h3978CrossRef
2.
3.
4.
Astrup A, Bertram HC, Bonjour J-P, de Groot LC, de Oliveira Otto MC, Feeney EL, Garg ML, Givens I, Kok FJ, Krauss RM, Lamarche B, Lecerf J-M, Legrand P, McKinley M, Micha R, Michalski M-C, Mozaffarian D, Soedamah-Muthu SS (2019) WHO draft guidelines on dietary saturated and trans fatty acids: time for a new approach? BMJ 366:l4137. https://​doi.​org/​10.​1136/​bmj.​l4137CrossRefPubMed
5.
Ricci C, Baumgartner J, Zec M, Kruger HS, Smuts CM (2018) Type of dietary fat intakes in relation to all-cause and cause-specific mortality in US adults: an iso-energetic substitution analysis from the american national health and nutrition examination survey LINKED to the US mortality registry. Br J Nutr 119(4):456–463CrossRef
6.
Chiu S, Williams PT, Krauss RM (2017) Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: a randomized controlled trial. PLoS ONE 12(2):e0170664CrossRef
7.
Hornstra G, Kester AD (1997) Effect of the dietary fat type on arterial thrombosis tendency: systematic studies with a rat model. Atherosclerosis 131(1):25–33CrossRef
8.
World Health Organization (2018) Draft guidelines on saturated fatty acid and trans-fatty acid intake for adults and children. World Health Organization, Geneva, Switzerland, p 103
9.
Vitolins MZ, Anderson AM, Delahanty L, Raynor H, Miller GD, Mobley C, Reeves R, Yamamoto M, Champagne C, Wing RR (2009) Action for health in diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake. J Am Diet Assoc 109(8):1367–1375CrossRef
10.
Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, Adetokunboh O, Afshin A, Agrawal A (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet 390(10100):1151–1210CrossRef
11.
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD (2018) Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 137(12):e67–e492CrossRef
12.
Cavender MA, Steg PG, Smith SC Jr, Eagle K, Ohman EM, Goto S, Kuder J, Im K, Wilson PW, Bhatt DL (2015) Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry. Circulation 132(10):923–931CrossRef
13.
14.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG (2019) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol 7(8):618–628. https://​doi.​org/​10.​1016/​s2213-8587(19)30158-5CrossRefPubMed
15.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med 6(7):e1000097CrossRef
16.
Mann J, De Leeuw I, Hermansen K, Karamanos B, Karlström B, Katsilambros N, Riccardi G, Rivellese A, Rizkalla S, Slama G (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14(6):373–394CrossRef
17.
18.
19.
Reynolds AN, Akerman AP, Mann J (2020) Dietary fibre and whole grains in diabetes management: systematic review and meta-analyses. PLoS medicine 17(3):e1003053CrossRef
20.
Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P, (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. oxford. asp, Ottawa
21.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA (2011) The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928CrossRef
22.
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRef
23.
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557CrossRef
24.
StataCorp, (2017) Stata statistical software: release 15. College Station, StataCorp LP, TX
25.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924CrossRef
26.
Soinio M, Laakso M, Lehto S, Hakala P, Rönnemaa T (2003) Dietary fat predicts coronary heart disease events in subjects with type 2 diabetes. Diabetes Care 26(3):619–624CrossRef
27.
Trichopoulou A, Psaltopoulou T, Orfanos P, Trichopoulos D (2006) Diet and physical activity in relation to overall mortality amongst adult diabetics in a general population cohort. J Intern Med 259(6):583–591CrossRef
28.
Campmans-Kuijpers MJ, Sluijs I, Nöthlings U, Freisling H, Overvad K, Boeing H, Masala G, Panico S, Tumino R, Sieri S, Johansson I, Winkvist A, Katzke VA, Kuehn T, Nilsson PM, Halkjær J, Tjønneland A, Spijkerman AM, Arriola L, Sacerdote C, Barricarte A, May AM, Beulens JW (2016) The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients. Clin Nutr 35(5):1096–1102. https://​doi.​org/​10.​1016/​j.​clnu.​2015.​08.​003CrossRefPubMed
29.
Tanasescu M, Cho E, Manson JE, Hu FB (2004) Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am j clin nutr 79(6):999–1005CrossRef
30.
31.
Heine R, Mulder C, Popp-Snijders C, Van Der Meer J, Van Der Veen E (1989) Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic patients. Am j clin nutr 49(3):448–456CrossRef
32.
Siri-Tarino PW, Sun Q, Hu FB, Krauss RM (2010) Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am j clin nutr 91(3):535–546CrossRef
33.
Mozaffarian D, Micha R, Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS medicine 7(3):e1000252CrossRef
34.
Hirahatake KM, Jiang L, Wong ND, Shikany JM, Eaton CB, Allison MA, Martin L, Garcia L, Zaslavsky O, Odegaard AO (2019) Diet quality and cardiovascular disease risk in postmenopausal women with type 2 diabetes mellitus: the women’s health initiative. J Am Heart Assoc 8(19):e013249CrossRef
35.
Sacks FM, Lichtenstein AH, Wu JH, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG (2017) Dietary fats and cardiovascular disease: a presidential advisory from the american heart association. Circulation 136(3):e1–e23CrossRef
36.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and european atherosclerosis society (EAS). Eur Heart J 41(1):111–188CrossRef
37.
Mensink RP, Zock PL, Kester AD, Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am j clin nutr 77(5):1146–1155CrossRef
38.
Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen M-R, Wiklund O et al (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and the european atherosclerosis society (EAS). Eur Heart J 32(14):1769–1818. https://​doi.​org/​10.​1093/​eurheartj/​ehr158CrossRefPubMed
39.
Mensink RP, World Health Organization (2016) Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis.
40.
Imamura F, Micha R, Wu JH, de Oliveira Otto MC, Otite FO, Abioye AI, Mozaffarian D (2016) Effects of saturated fat, polyunsaturated fat, monounsaturated fat, and carbohydrate on glucose-insulin homeostasis: a systematic review and meta-analysis of randomised controlled feeding trials. PLoS medicine 13(7):e1002087CrossRef
41.
42.
43.
US Department of Health and Human Services; US Department of Agriculture (2015) 2015–2020 Dietary guidelines for americans, 8th edn. US Dept of Health and Human Services, Washington DC
Metadata
Title
Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis
Authors
Ursula Schwab
Andrew N. Reynolds
Taisa Sallinen
Angela Albarosa Rivellese
Ulf Risérus
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Keyword
Type 2 Diabetes
Published in
European Journal of Nutrition / Issue 6/2021
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02507-1

Other articles of this Issue 6/2021

European Journal of Nutrition 6/2021 Go to the issue

Original Contribution

Diet quality indices and dietary patterns are associated with plasma metabolites in colorectal cancer patients

Original Contribution

Associations between maternal vitamin D status during three trimesters and cord blood 25(OH)D concentrations in newborns: a prospective Shanghai birth cohort study

Original Contribution

Co-ingestion of NUTRALYS® pea protein and a high-carbohydrate beverage influences the glycaemic, insulinaemic, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) responses: preliminary results of a randomised controlled trial

Original Contribution

Dietary patterns of Australian pre-schoolers and associations with haem and non-haem iron intakes

Original Contribution

Co-administration of viscous fiber, Salba-chia and ginseng on glycemic management in type 2 diabetes: a double-blind randomized controlled trial

Original Contribution

Sleep and physical activity in healthy 8–9-year-old children are affected by oily fish consumption in the FiSK Junior randomized trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits